Nav: Home

TGen joins with Banner Health to study sports-related brain injuries

December 14, 2016

PHOENIX, Ariz. -- Dec. 14, 2016 -- Banner Health and the Translational Genomics Research Institute (TGen) today announced a partnership to find a quicker and more accurate way of diagnosing concussions.

Specifically, Banner and TGen will obtain bio-samples from as many as 100 volunteer patients in an effort to find a biomarker -- a genetic signature -- that can definitively indicate when a patient has suffered a concussion, and when they have recovered.

Currently, there is no test or imaging system that can objectively indicate when a patient has sustained a concussion.

The RNA from patients' bio-samples -- blood, urine and saliva -- will be analyzed at the molecular level using TGen's next-generation sequencing and super-computing, which spells-out the billions of chemical letters in each patient's genome.

"For the first time, we will be able to access whether or not there is an accumulation of head trauma biomarkers from concussive and repeated sub-concussive impacts," said Dr. Kendall Van Keuren-Jensen, an Associate Professor in TGen's Neurogenomics Division. "This information would be extremely beneficial to physicians as they treat and monitor their patients."

The study will focus primarily on patients, age 15 and older, that sustain sports-related concussions. Their bio-samples will be used to identify molecular changes associated with clinically diagnosed concussions.

"Little is known about how to interpret the severity of head injuries or the potential for long-term consequences that result from such injuries," said Dr. Steven Erickson, Medical Director of the Banner Concussion Center, and the study's principle investigator.

"Currently, there is no definitive test to quickly and accurately diagnose a concussion, or to determine when the brain has fully recovered," said Dr. Erickson, who also is the Co-Chief of the Banner-University Sports Medicine Center, and the Program Director of the Primary Care Sports Medicine Fellowship at the University of Arizona College of Medicine-Phoenix.

TGen also is conducting a related brain-injury study in association with the Barrow Neurological Institute (BNI) and Arizona State University.

Findings from this new TGen-Banner study will be compared to the three-year TGen-BNI study, in which bio-samples from the student athletes on the ASU Sun Devils football team were correlated with data from helmet sensors that tracked the number, direction and intensity of head impacts recorded by a wireless sideline computer during games and practices. That study, led by Drs. Van Keuren-Jensen and Matt Huentelman, a Professor in TGen's Neurogenomics Division, was sponsored in part by Riddell, the football industry's leader in helmet technology and innovation.

In TGen's new study with Banner, bio-samples from concussion patients will be collected weekly and assessed for potential genetic biomarkers. That information will be correlated with changes in the patients' vision, balance, sleep and concentration.

A quick and simple blood test using genetic biomarkers would let physicians -- especially emergency room and primary care doctors -- know when patients have suffered a significant brain injury, and when they have recovered. It also could help identify those at risk for long-term complications, help develop new therapies to address injuries, and help assess the damage from repeated mild trauma.

Data collected and assessed from all participants in the study would be de-identified, or coded, to ensure the privacy and anonymity of the patients.
About TGen

Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with neurological disorders, cancer, and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. TGen is allied with City of Hope, a world-renowned independent research and cancer and diabetes treatment center. This precision medicine alliance enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. For more information, visit: Follow TGen on Facebook, LinkedIn and Twitter @TGen.

About Banner Health

Headquartered in Arizona, Banner Health is one of the largest nonprofit health care systems in the country. The system owns and operates 29 acute-care hospitals, Banner Health Network, Banner - University Medicine, Banner Medical Group, long-term care centers, outpatient surgery centers and an array of other services, including family clinics, home care and hospice services, pharmacies and a nursing registry. Banner Health is in seven states: Alaska, Arizona, California, Colorado, Nebraska, Nevada and Wyoming. For more information, visit

Media Contact:
Steve Yozwiak
TGen Senior Science Writer

The Translational Genomics Research Institute

Related Concussion Articles:

Biomarkers may help us understand recovery time after concussion
A blood test may help researchers understand which people may take years to recover from concussion, according to a study published in the May 27, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Study provides the first data on concussion risk in youth football
'These are the first biomechanical data characterizing concussion risk in kids,' said Steve Rowson, an associate professor of biomedical engineering and mechanics and the director of the Virginia Tech Helmet Lab.
Concussion alters how information is transmitted within the brain
Damage from concussion alters the way information is transmitted between the 2 halves of the brain, according to a new study.
Concussion recovery not clear cut for children
Sleep problems, fatigue and attention difficulties in the weeks after a child's concussion injury could be a sign of reduced brain function and decreased grey matter.
A concussion can cost your job -- especially if you are young and well educated
A seemingly harmless concussion can cause the loss of a job -- especially for patients who are in their thirties and for those with a higher education.
After concussion, biomarkers in the blood may help predict recovery time
A study of high school and college football players suggests that biomarkers in the blood may have potential use in identifying which players are more likely to need a longer recovery time after concussion, according to a study published in the July 3, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.
Concussion is a leading cause of injury for children in recreational sports
In a two-year study of children between ages 5-11 who play recreational sports, more suffered concussions than most any other sports-related injury.
Concussion symptoms reversed by magnetic therapy
Concussion symptoms -- such as loss of balance and ability to walk straight -- can be reversed by a new type of magnetic stimulation
Study paves way for better treatment of lingering concussion symptoms
The results of the study, released in Neuroscience journal, show that significant levels of fatigue and poorer brain function can persist for months, or even years, following concussion.
What makes athletes report or hide concussion symptoms?
Whether or not an NCAA Division I athlete is likely to report concussion symptoms depends on factors including their vested interests, their understanding of health implications, and their team culture and societal influences drawn from narratives of performance circulating in media, according to a study published May 8, 2019 in the open-access journal PLOS ONE by Steven Corman of Arizona State University, USA, and colleagues.
More Concussion News and Concussion Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Making Amends
What makes a true apology? What does it mean to make amends for past mistakes? This hour, TED speakers explore how repairing the wrongs of the past is the first step toward healing for the future. Guests include historian and preservationist Brent Leggs, law professor Martha Minow, librarian Dawn Wacek, and playwright V (formerly Eve Ensler).
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.